018373332

BIOWAYS CDMO

---

January 11, 2021

Trademark Summary

The trademark application BIOWAYS CDMO was filed by GTP Bioways, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on January 27, 2021, and it was registered by office on May 6, 2021 without any oppositions.

The application was filed in French (English was selected as the second language).

Change of name and address of the trademark registration was recorded on November 23, 2021.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals
  2. Cardiovascular pharmaceuticals
  3. Diaphoretics
  4. Lactagogues
  5. Anti-diabetic pharmaceuticals
  6. Dermatological pharmaceutical products
  7. Anti-epileptic pharmaceutical preparations
  8. Antibacterial pharmaceuticals
  9. Injectable pharmaceuticals
  10. Chemico-pharmaceutical preparations
  11. Parenteral anti-epileptic pharmaceutical preparations
  12. Pharmaceutical products for ophthalmological use
  13. Antiarrhythmic agents
  14. Anti-sarcoma preparations
  15. Pharmaceuticals and natural remedies
  16. Pharmaceutical preparations for treating dandruff
  17. Ocular pharmaceuticals
  18. Pharmaceutical preparations for use in ophthalmology
  19. Pharmaceutical preparations for use in hematology
  20. Pharmaceutical preparations for skin wounds
  21. Acne creams [pharmaceutical preparations]
  22. Cerebral hemorrhage prophylactic agents
  23. Cholesterol reducers
  24. Anti-cancer preparations
  25. Oral anti-epileptic pharmaceutical preparations
  26. Pharmaceutical products and preparations for chloasma
  27. Pharmaceutical preparations for the prevention of allergies
  28. Pharmaceutical preparations for the prevention of diabetes
  29. Pharmaceutical preparations for hair care
  30. Pharmaceutical preparations for use in tissue transplantation
  31. Pharmaceuticals for the treatment of erectile dysfunction
  32. Pharmaceutical products for the treatment of bone diseases
  33. Pharmaceutical products for treating respiratory diseases
  34. Pharmaceutical preparations for the treatment of bone fractures
  35. Pharmaceutical products for the treatment of infectious diseases
  36. Pharmaceutical preparations for the treatment of hypercholesteremia
  37. Pharmaceutical preparations for the treatment of hyperlipidemia
  38. Pharmaceutical preparations for the treatment of hormonal disorders
  39. Filled syringes for medical purposes [containing pharmaceuticals]
  40. Pharmaceutical preparations for skin care
  41. Pharmaceutical preparations for the treatment of epilepsy
  42. Pharmaceutical preparations for treating hypoglycemia
  43. Pharmaceutical preparations for treating halitosis
  44. Pharmaceutical preparations for the prevention of inflammatory diseases
  45. Pharmaceutical preparations for the treatment of kidney diseases
  46. Pharmaceutical preparations for the treatment of diseases caused by bacteria
  47. Pharmaceutical preparations for the treatment of inflammatory diseases
  48. Pharmaceutical preparations for the treatment of kidney disorders
  49. Pharmaceutical preparations for treating arthritis
  50. Pharmaceutical products for the treatment of depression
  51. Pharmaceutical preparations for the prevention of ocular diseases
  52. Pharmaceutical preparations for use in organ transplantation
  53. Pharmaceutical preparations for the prevention of inflammatory disorders
  54. Pharmaceutical preparations for the treatment of inflammatory disorders
  55. Pharmaceutical preparations for the prevention of ocular disorders
  56. Pharmaceutical products and preparations to prevent stretch marks
  57. Pharmaceutical preparations for treating allergic rhinitis
  58. Pharmaceutical preparations for the treatment of musculo-skeletal disorders
  59. Injectable pharmaceuticals for treatment of anaphylactic reactions
  60. Pharmaceutical preparations for treating gastrointestinal disorders
  61. Pharmaceutical preparations for the prevention of autoimmune disorders
  62. Pharmaceutical preparations for the treatment of autoimmune disorders
  63. Pharmaceutical preparations for treating skeletal diseases
  64. Pharmaceutical preparations for the prevention of autoimmune diseases
  65. Pharmaceutical preparations for animal skincare
  66. Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
  67. Pharmaceutical preparations for treating digestive system disorders
  68. Pharmaceutical preparations for treating epidermal problems
  69. Pharmaceutical preparations for treating sensory organ disorders
  70. Pharmaceutical preparations for the prevention of disorders of the metabolic system
  71. Pharmaceutical preparations for the prevention of disorders of the immune system
  72. Pharmaceutical preparations for the prevention of disorders of the nervous system
  73. Pharmaceutical preparations for the prevention of diseases of the nervous system
  74. Pharmaceutical preparations for the prevention of diseases of the immune system
  75. Pharmaceutical preparations for the treatment of diseases of the metabolic system
  76. Pharmaceutical preparations for the treatment of diseases of the endocrine system
  77. Pharmaceutical preparations for the treatment of disorders of the metabolic system
  78. Pharmaceutical preparations for the prevention of disorders of the endocrine system
  79. Pharmaceutical preparations for the treatment of disorders of the endocrine system
  80. Pharmaceutical preparations for the prevention of diseases of the metabolic system
  81. Pharmaceutical preparations for the prevention of diseases of the respiratory system
  82. Pharmaceutical preparations for the prevention of disorders of the respiratory system
  83. Pharmaceutical preparations for the prevention of disorders caused by bacteria
  84. Pharmaceutical preparations for the prevention of diseases caused by bacteria
  85. Pharmaceutical products and preparations to prevent swelling in the legs
  86. Pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system
  87. Pharmaceutical preparations for the treatment of disorders of the genitourinary system
  88. Pharmaceutical preparations for the prevention of disorders of the musculo-skeletal system
  89. Pharmaceutical preparations for the prevention of disorders of the genitourinary system
  90. Pharmaceutical preparations for the prevention of diseases of the genitourinary system
  91. Pharmaceutical preparations for the treatment of disorders caused by bacteria
  92. Pharmaceutical preparations for the treatment of diseases of the genitourinary system
  93. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
  94. Drug delivery agents that facilitate the delivery of pharmaceutical preparations
  95. Pharmaceutical products and preparations for hydrating the skin during pregnancy
  96. Pharmaceutical products and preparations for preventing skin blemishes during pregnancy
  97. Pharmaceutical products and preparations for pregnancy blemishes.
• The mark was filed in class 42 with following description of goods:
  
  1. Pharmaceutical drug development services
  2. Laboratory services relating to the production of monoclonal antibodies
  3. Medical research laboratory services
  4. Medical laboratory services
  5. Conducting early evaluations in the field of new pharmaceuticals
  6. Pharmaceutical product evaluation
  7. Testing of pharmaceuticals
  8. Laboratory research services relating to pharmaceuticals.